Antares Pharma Inc ATRS:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 02/26/21 EST
4.26quote price arrow up+0.01 (+0.24%)
Volume
351,216
Close
4.25quote price arrow down-0.22 (-4.92%)
Volume
1,538,529
52 week range
1.60 - 5.07

...

Loading . . .

KEY STATS

  • Open4.52
  • Day High4.54
  • Day Low4.25
  • Prev Close4.47
  • 52 Week High5.07
  • 52 Week High Date02/18/21
  • 52 Week Low1.60
  • 52 Week Low Date03/23/20
  • Market Cap708.35M
  • Shares Out166.67M
  • 10 Day Average Volume1.79M
  • Dividend-
  • Dividend Yield-
  • Beta1.42
  • 1 Year % Change41.67

RATIOS/PROFITABILITY

  • EPS (TTM)0.06
  • P/E (TTM)74.96
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)15.459M
  • ROE (MRQ)17.35%
  • Revenue (MRQ)143.31M
  • Gross Margin (MRQ)59.48%
  • Net Margin (MRQ)6.64%
  • Debt To Equity (MRQ)62.50%

EVENTS

  • Earnings Date03/02/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Antares Pharma Inc News

There is no recent news for this security.

Latest ATRS News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Antares Pharma, Inc. (Antares) is a specialty pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies. The Company develops and manufactures pressure-assisted injector devices, with and without needles, which allow patients to self-inject drugs. The Company's subcutaneous injection technology platforms include VIBEX disposable pressure-assisted auto injectors, Vision reusable needle-free...
Leonard Jacob M.D., Ph.D.
Chairman
Robert Apple CPA
President
Fred Powell CPA
Chief Financial Officer
Peter Graham
Executive Vice President
Address
SUITE 300, 100 PRINCETON SOUTH
Ewing, NJ
8628
United States